GRTX
Price:
$0.053
Market Cap:
$2.88M
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing ...[Read more]
Industry
Biotechnology
IPO Date
2019-11-07
Stock Exchange
NASDAQ
Ticker
GRTX
According to Galera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -71.83% compared to the average of -0.36 of the last 4 quarters.
The mean historical PE Ratio of Galera Therapeutics, Inc. over the last ten years is -4.20. The current -0.10 PE Ratio has changed 138.13% with respect to the historical average. Over the past ten years (40 quarters), GRTX's PE Ratio was at its highest in in the September 2023 quarter at -0.13. The PE Ratio was at its lowest in in the September 2018 quarter at -11.07.
Average
-4.20
Median
-3.43
Minimum
-9.81
Maximum
-0.11
Discovering the peaks and valleys of Galera Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 26.48%
Maximum Annual PE Ratio = -0.11
Minimum Annual Increase = -83.10%
Minimum Annual PE Ratio = -9.81
Year | PE Ratio | Change |
---|---|---|
2023 | -0.11 | -83.10% |
2022 | -0.65 | -51.93% |
2021 | -1.35 | -60.64% |
2020 | -3.43 | -45.48% |
2019 | -6.29 | -35.93% |
2018 | -9.81 | 26.48% |
The current PE Ratio of Galera Therapeutics, Inc. (GRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.70
5-year avg
-2.36
10-year avg
-4.20
Galera Therapeutics, Inc.’s PE Ratio is greater than Mereo BioPharma Group plc (-17.93), greater than Terns Pharmaceuticals, Inc. (-5.67), greater than PDS Biotechnology Corporation (-2.97), greater than Inozyme Pharma, Inc. (-2.64), greater than HOOKIPA Pharma Inc. (-0.97), less than X4 Pharmaceuticals, Inc. (7.02), greater than Acumen Pharmaceuticals, Inc. (-3.03), greater than Day One Biopharmaceuticals, Inc. (-18.95), greater than Amylyx Pharmaceuticals, Inc. (-1.76),
Company | PE Ratio | Market cap |
---|---|---|
-17.93 | $655.41M | |
-5.67 | $616.38M | |
-2.97 | $121.14M | |
-2.64 | $252.19M | |
-0.97 | $45.33M | |
7.02 | $104.05M | |
-3.03 | $196.46M | |
-18.95 | $1.65B | |
-1.76 | $456.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Galera Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Galera Therapeutics, Inc. (GRTX)?
What is the highest PE Ratio for Galera Therapeutics, Inc. (GRTX)?
What is the 3-year average PE Ratio for Galera Therapeutics, Inc. (GRTX)?
What is the 5-year average PE Ratio for Galera Therapeutics, Inc. (GRTX)?
How does the current PE Ratio for Galera Therapeutics, Inc. (GRTX) compare to its historical average?